Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDImageneBio Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$1.11 | -$0.92 | -$1.02 |
| Q2 2026 | 3 | -$0.95 | -$0.66 | -$0.80 |
| Q3 2026 | 3 | -$1.01 | -$0.76 | -$0.91 |
| Q1 2027 | 1 | -$0.79 | -$0.79 | -$0.79 |
| Q2 2027 | 1 | -$0.84 | -$0.84 | -$0.84 |
| Q3 2027 | 1 | -$0.93 | -$0.93 | -$0.93 |
| Q4 2027 | 1 | -$1.10 | -$1.10 | -$1.10 |
| Q1 2028 | 2 | -$0.75 | -$0.75 | -$0.75 |
| Q2 2028 | 2 | -$0.71 | -$0.71 | -$0.71 |
| Q3 2028 | 2 | -$0.68 | -$0.68 | -$0.68 |
| Q4 2028 | 2 | -$0.68 | -$0.68 | -$0.68 |
| Q1 2029 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q2 2029 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q3 2029 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q4 2029 | 1 | -$0.23 | -$0.23 | -$0.23 |
ImageneBio Inc. Earnings Date And Information
ImageneBio Inc. last posted its earnings results on Wednesday, August 5th, 2026. The company reported $-0.63 earnings per share for the quarter, topping analysts' consensus estimates of $-0.97667 by $0.34667. The company had revenue of 0 for the quarter and had revenue of 800.00 K for the year. ImageneBio Inc. has generated $-10 earnings per share over the last year ($-9.64 diluted earnings per share) and currently has a price-to-earnings ratio of -0.82. ImageneBio Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
ImageneBio Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2026 | Q2 2026 | -$0.98 | -$0.63 | 0.35 | $0 | $0 |
| 05/07/2026 | Q1 2026 | -$0.70 | -$0.95 | -0.25 | N/A | $0 |
| 03/10/2026 | Q4 2025 | N/A | -$0.62 | N/A | N/A | $0 |
| 11/12/2025 | Q3 2025 | -$1.47 | -$3.01 | -1.54 | N/A | $0 |
| 07/24/2025 | Q2 2025 | -$0.14 | -$4.46 | -4.32 | N/A | $0 |
| 05/08/2025 | Q1 2025 | -$0.21 | -$6.47 | -6.26 | N/A | $800.00 K |
| 03/06/2025 | Q4 2024 | -$0.23 | -$5.58 | -5.35 | $875.00 K | $0 |
| 11/07/2024 | Q3 2024 | -$0.27 | -$4.41 | -4.14 | N/A | $0 |
| 08/08/2024 | Q2 2024 | N/A | -$3.41 | N/A | N/A | $0 |
| 05/13/2024 | Q1 2024 | -$0.41 | -$4.01 | -3.6 | $2.33 M | $0 |
| 03/12/2024 | Q4 2023 | -$0.43 | -$4.89 | -4.46 | $2.44 M | $659.00 K |
| 11/09/2023 | Q3 2023 | N/A | -$4.79 | N/A | $2.84 M | $1.19 M |
| 09/12/2023 | Q2 2023 | N/A | -$5.23 | N/A | $3.85 M | $2.00 M |
| 05/15/2023 | Q1 2023 | -$0.47 | -$4.71 | -4.24 | $4.61 M | $5.31 M |
| 03/14/2023 | Q4 2022 | N/A | -$4.67 | N/A | $6.02 M | $5.45 M |
| 11/07/2022 | Q3 2022 | -$0.50 | -$5.74 | -5.24 | $4.32 M | $6.40 M |
| 08/11/2022 | Q2 2022 | -$0.49 | -$6.80 | -6.31 | $3.87 M | $382.00 K |
| 05/12/2022 | Q1 2022 | -$0.42 | -$5.60 | -5.18 | $4.57 M | $3.38 M |
| 03/17/2022 | Q4 2021 | -$0.51 | $0.93 | 1.44 | $4.79 M | $20.22 M |
| 11/10/2021 | Q3 2021 | -$0.42 | -$4.85 | -4.43 | $4.05 M | $3.75 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ImageneBio Inc. Earnings: FAQ's
In the previous quarter, ImageneBio Inc. (:IMA) reported $-0.63 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.97667 by $0.34667.
The conference call for ImageneBio Inc.'s latest earnings report can be listened to online.
The conference call transcript for ImageneBio Inc.'s latest earnings report can be read online.
ImageneBio Inc. (:IMA) has a recorded annual revenue of $800.00 K.
ImageneBio Inc. (:IMA) has a recorded net income of $-45,349,000.ImageneBio Inc. has generated $-9.64 earnings per share over the last four quarters.
ImageneBio Inc. (:IMA) has a price-to-earnings ratio of -0.82 and price/earnings-to-growth ratio is -0.01.